Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 20518-20537

  Barone, Maria Vittoria ^a   Troncone, Riccardo ^a   Auricchio, Salvatore ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Actin; Celiac disease; Cellular stress; Epithelial growth factor epithelial growth factor receptor (EGF EGFR); Gliadin; Gliadin peptides; Innate immunity; Interleukin 15 interleukin 15 receptor (IL 15 IL 15R ); Peptide 31 43 (P31 43); Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLIADIN; GLIADIN PEPTIDE [31-43]; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; SCATTER FACTOR; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR; GLIADIN P31-43; PEPTIDE FRAGMENT;

CELIAC DISEASE; CELL DAMAGE; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CELL STRESS; CELL TRANSPORT; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; INTRACELLULAR SIGNALING; LAMINA PROPRIA; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; IMMUNOLOGY; INTESTINE CELL; INTESTINE MUCOSA; PATHOLOGY; SMALL INTESTINE;

ANIMALS; CELIAC DISEASE; CELL PROLIFERATION; ENTEROCYTES; EPIDERMAL GROWTH FACTOR; GLIADIN; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-15; INTESTINAL MUCOSA; INTESTINE, SMALL; PEPTIDE FRAGMENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84910120496     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151120518     Document Type: Review

References (91)

1. Veldhoen, M.; Brucklacher-Waldert, V. Dietary influences on intestinal immunity. Nat. Rev. Immunol. 2012, 12, 696-708.
2. Marsh, M.N. Clinical and pathological spectrum of coeliac disease. Gut 1993, 34, 1740-1741.
3. Marsh, M.N.; Crowe, P.T. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin. Gastroenterol. 1995, 9, 273-293.
4. Marsh, M.N.; Loft, D.E.; Garner, V.G. Time/dose responses of coeliac mucosae to graded oral challenges with Frazer’s fraction III of gliadin. Eur. J. Gastroenterol. Hepatol. 1992, 4, 667-674.
5. Shan, L.; Molberg, Ø.; Parrot, I.; Hausch, F.; Filiz, F.; Gray, G.M.; Sollid, L.M.; Khosla, C. Structural basis for gluten intolerance in Celiac Sprue. Science 2002, 297, 2275-2279.
6. Comino, I.; Real, A.; Vivas, S.; Síglez, M.Á.; Caminero, A.; Nistal, E.; Casqueiro, J.; Rodríguez-Herrera, A.; Cebolla, A.; Sousa, C. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am. J. Clin. Nutr. 2012, 95, 670-677.
7. Mamone, G.; Ferranti, P.; Rossi, M.; Roepstorff, P.; Fierro, O.; Malorni, A.; Addeo, F. Identification of a peptide from α-gliadin resistant to digestive enzymes: Implications for celiac disease. In Proceedings of the 44th Scientific Meeting of The International Association of Forensic Toxicologists, Ljubljana, Slovenia, 27 August-1 September 2006.
8. Nanayakkara, M.; Lania, G.; Maglio, M.; Discepolo, V.; Sarno, M.; Gaito, A.; Troncone, R.; Auricchio, S.; Auricchio, R.; Barone, M.V. An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease. Am. J. Clin. Nutr. 2013, 98, 1123-1135.
9. Sollid, L.M. Molecular basis of celiac disease. Annu. Rev. Immunol. 2000, 18, 53-81
10. De Ritis, G.; Auricchio, S.; Jones, H.W.; Lew, E.J.; Bernardin, J.E.; Kasarda, D.D. In vitro (organ culture) studies of the toxicity of specificα-gliadin peptides in celiac disease. Gastroenterology 1988, 94, 41-49.
11. Sturgers, R.; Day, P.; Ellis, H.J.; Lundin, K.E.; Gjertsen, H.A.; Kontakou, M.; Ciclitira, P. J. Wheat peptide challenge in coeliac disease. Lancet 1994, 343, 758-761.
12. Maiuri, L.; Troncone, R.; Mayer, M.; Coletta, S.; Picarelli, A.; de Vincenzi, M.; Pavone, V.; Auricchio, S. In vitro activities of α-gliadin-related synthetic peptides: Damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. Scand. J. Gastroenterol. 1996, 31, 247-253.
13. Jabri, B.; Sollid, L.M. Mechanisms of disease: Immunopathogenesis of celiac disease. Nat. Clin. Pract. Gastoenterol. Hepathol. 2006, 3, 516-525.
14. Abadie, V.; Sollid, L.; Barreiro, L.B.; Jabri, B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu. Rev. Immunol. 2010, 29, 493-526.
15. Maiuri, L.; Ciacci, C.; Ricciardelli, I.; Vacca, L.; Raia, V.; Auricchio, S.; Picard, J.; Osman, M.; Quaratino, S.; Londei, M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003, 362, 30-37.
16. Hue, S.; Mention, J.J.; Monteiro, R.C.; Zhang, S.; Cellier, C.; Schmitz, J.; Verkarre, V.; Fodil, N.; Bahram, S.; Cerf-Bensussan, N., et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004, 21, 367-377.
17. Barone, M.V.; Gimigliano, A.; Castoria, G.; Paolella, G.; Maurano, F.; Paparo, F.; Maglio, M.; Mineo, A.; Miele, E.; Nanayakkara, M., et al. Growth factor-like activity of gliadin, an alimentary protein: Implications for coeliac disease. Gut 2007, 56, 480-488.
18. Juuti-Uusitalo, K.; Maki, M.; Kainulainen, H.; Isola, J.; Kaukinen, K. Gluten affects epithelial differentiation-associated genes in small intestinal mucosa of coeliac patients. Clin. Exp. Immunol. 2007, 150, 294-305.
19. Clemente, M.G.; de Virgiliis, S.; Kang, J.S.; Macatagney, R.; Musu, M.P.; di Pierro, M.R.; Drago, S.; Congla, M.; Fasano, A. Early effects of gliadin on enterocytes intracellular signalling involved in intestinal barrier function. Gut 2003, 52, 218-223.
20. Ménard, S.; Lebreton, C.; Schumann, M.; Matysiak-Budnik, T.; Dugave, C.; Bouhnik, Y.; Malamut, G.; Cellier, C.; Allez, M; Crenn, P., et al. Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am. J. Pathol. 2012, 180, 608-615.
21. Silano, M.; Vincentini, O.; Luciani, A.; Felli, C.; Caserta, S.; Esposito, S.; Villella, V.R.; Pettoello-Mantovani, M.; Guido, S.; Maiuri, L. Early tissue transglutaminase-mediated response underlies K562(S)-cell gliadin dependent agglunation. Pediatr. Res. 2012, 71, 532-538.
22. Thomas, K.E.; Sapone, A.; Fasano, A.; Vogel, S.N. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: Role of the innate immune response in celiac disease. J. Immunol. 2006, 15, 2512-2521.
23. Caputo, I.; Secondo, A.; Lepretti, M.; Paolella, G.; Auricchio, S.; Barone, M.V.; Esposito, C. Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells. PLoS One 2012, 7, e45209.
24. Palová-Jelínková, L.; Dáňová, K.; Drašarová, H.; Dvořák, M.; Funda, D.P.; Fundová, P.; Kotrbová-Kozak, A.; Černá, M.; Kamanová, J.; Martin, S.F., et al. Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation. PLoS One 2013, 8, e62426.
25. Parmar, A.; Greco, D.; Venäläinen, J.; Gentile, M.; Dukes, E.; Saavalainen, P. Gene expression profiling of gliadin effects on intestinal epithelial cells suggests novel non-enzymatic functions of pepsin and trypsin. PLoS One 2013, 8, e66307.
26. Rivabene, R.; Mancini, E.; de Vincenzi, M. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: Implications for celiac disease. Biochim. Biophys. Acta 1999, 1453, 152-160.
27. Reinecker, H.C.; MacDermott, R.P.; Mirau, S.; Dignass, A.; Podolsky, D.K. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996, 111, 1706-1713
28. Bamford, R.N.; Battiata, A.P.; Waldmann, T.A. IL-15: The role of translational regulation in their expression. J. Leukoc. Biol. 1996, 59, 476-480.
29. Bamford, R.N.; Battiata, A.P.; Waldmann, T.A. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000, 119, 996-1006.
30. Mention, J.J.; Ben Ahmed, M.; Bègue, B.; Barbe, U.; Verkarre, V.; Asnafi, V.; Colombel, J.F.; Cugnenc, P.H.; Ruemmele, F.M.; McIntyre, E., et al. Interleukin 15: A key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003, 125, 730-745.
31. Bernardo, D.; Garrote, J.A.; Allegretti, Y.; León, A.; Gómez, E.; Bermejo-Martin, J.F.; Calvo, C.; Riestra, S.; Fernández-Salazar, L.; Blanco-Quirós, A., et al. Higher constitutive IL-15R-α expression and lower IL-15 response threshold in coeliac disease patients. Clin. Exp. Immunol. 2008, 154, 64-73.
32. Hmida, N.B.; Ahmed, M.B.; Moussa, A.; Rejeb, M.B.; Said, Y.; Kourda, N.; Meresse, B.; Abdeladhim, M.; Louzir, H.; Cerf-Bensussan, N. Impaired control of effector T cells by regulatory T cells: A clue to loss of oral tolerance and autoimmunity in celiac disease? Am. J. Gastroenterol. 2012, 107, 604-611.
33. Di Sabatino, A.; Ciccocioppo, R.; Cupelli, F.; Cinque, B.; Millimaggi, D.; Clarkson, M.M.; Paulli, M.; Cifone, M.G.; Corazza, G.R. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006, 55, 469-477.
34. Maglio, M.; Mazzarella, G.; Barone, M.V.; Gianfrani, C.; Pogna, N.; Gazza, L.; Stefanile, R.; Camarca, A.; Colicchio, B.; Nanayakkara, M., et al. Immunogenicity of two oat varieties, in relation to their safety for celiac patients. Scand. J. Gastroenterol. 2011, 46, 1194-1205.
35. Zanzi, D.; Stefanile, R.; Santagata, S.; Iaffaldano, L.; Iaquinto, G.; Giardullo, N.; Lania, G.; Vigliano, I.; Vera, A.R.; Ferrara, K., et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease. Am. J. Gastroenterol. 2011, 106, 1308-1317.
36. Benahmed, M.; Meresse, B.; Arnulf, B.; Barbe, U.; Mention, J.J.; Verkarre, V.; Allez, M.; Cellier, C.; Hermine, O.; Cerf-Bensussan, N. Inhibition of TGF-β signaling by IL-15: A new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007, 132, 994-1008.
37. Ahmed, M.B.; Hmida, N.B.; Moes, N.; Buyse, S.; Abdeladhim, M.; Louzir, H.; Cerf-Bensussan, N. IL-15 Renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 2009, 182, 6763-6770.
38. De Paolo, R.W.; Abadie, V.; Tang, F.; Fehlner-Peach, H.; Hall, J.A.; Wang, W.; Marietta, E.V.; Kasarda, D.D.; Waldmann, T.A.; Murray, J.A., et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011, 471, 220-224.
39. Jabri, B.; de Serre, N.P.; Cellier, C.; Evans, K.; Gache, C.; Carvalho, C.; Mougenot, J.F.; Allez, M.; Jian, R.; Desreumaux, P., et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000, 118, 867-879.
40. Meresse, B.; Chen, Z.; Ciszewski, C.; Tretiakova, M.; Bhagat, G.; Krausz, T.N.; Raulet, D.H.; Lanier, L.L.; Groh, V.; Spies, T., et al. Coordinated induction by IL-15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21, 357-366.
41. Yokoyama, S.; Watanabe, N.; Sato, N.; Perera, P.Y.; Filkoski, L.; Tanaka, T.; Miyasaka, M.; Waldmann, T.A.; Hiroi, T.; Perera, L.P. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc. Natl. Acad. Sci. USA 2009, 106, 15849-15854.
42. Yokoyama, S.; Takada, K.; Hirasawa, M.; Perera, L.P.; Hiroi, T. Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T Cell-mediated pathologic manifestations of celiac disease. J. Clin. Immunol. 2011, 31, 1038-1044.
43. Abadie, V.; Jabri, B. IL-15: A central regulator of celiac disease immunopathology. Immunol. Rev. 2014, 260, 221-234.
44. Diosdado, B.; Wapenaar, M.C.; Franke, L.; Duran, K.J.; Goerres, M.J.; Hadithi, M.; Crusius, J.B.; Meijer, J.W.; Duggan, D.J.; Mulder, C.J., et al. A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut 2004, 53, 944-951.
45. Capuano, M.; Iaffaldano, L.; Tinto, N.; Montanaro, D.; Capobianco, V.; Izzo, V.; Tucci, F.; Troncone, G.; Greco, L.; Sacchetti, L. MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS One 2011, 6, e29094.
46. Reinke, Y.; Behrendt, M.; Schmidt, S.; Zimmer, K.P.; Naim, H.Y. Impairment of protein trafficking by direct interaction of gliadin peptides with actin. Exp. Cell. Res. 2011, 317, 2124-2135.
47. Zimmer, K.P.; Fischer, I.; Mothes, T.; Weissen-Plenz, G.; Schmitz, M.; Wieser, H.; Büning, J.; Lerch, M.M.; Ciclitira, P.C.; Weber, P., et al. Endocytotic segregation of gliadin peptide 31-49 in enterocytes. Gut 2010, 59, 300-310.
48. Barone, M.V.; Zanzi, D.; Maglio, M.; Nanayakkara, M.; Santagata, S.; Lania, G.; Miele, E.; Ribecco, M.T.; Maurano, F.; Auricchio, R., et al. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One 2011, 6, e17039.
49. Moestrup, S.K. How calcium makes endocytic receptors attractive. Trends Biochem. Sci. 2014, 39, 82-90.
50. Scita, G.; di Fiore, P.P. The endocytic matrix. Nature 2010, 463, 464-473.
51. Barone, M.V.; Nanayakkara, M.; Paolella, G.; Maglio, M.; Vitale, V.; Troiano, R.; Ribecco, M.T.; Lania, G.; Zanzi, D.; Santagata, S., et al. Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation. PLoS One 2010, 5, e12246.
52. Raiborg C.; Stenmark, H. Hrs and endocytic sorting of ubiquitinated membrane proteins. Cell Struct. Funct. 2002, 27, 403-408.
53. Hayakawa, A.; Kitamura, N. Early endosomal localization of hrs requires a sequence within the proline-and glutamine-rich region but not the FYVE finger. J. Biol. Chem. 2000, 275, 29636-29642.
54. Pullan, L.; Mullapudi, S.; Huang, Z.; Baldwin, P.R.; Chin, C.; Sun, W.; Tsujimoto, S.; Kolodziej, S.J.; Stoops, J.K.; Lee, J.C., et al. The endosome-associated protein hrs is hexameric and controls cargo sorting as a “master molecule”. Structure 2006, 14, 661-671.
55. Bouamr, F.; Houck-Loomis, B.R.; de Los Santos, M.; Casaday, R.J.; Johnson, M.C. The C-terminal portion of the Hrs protein interacts with Tsg101 and Interferes with human immunodeficiency virus type 1 Gag particle production. J. Virol. 2007, 81, 2909-2922.
56. Raiborg, C.; Malerød, L.; Pedersen, N.M.; Stenmark, H. Differential functions of Hrs and ESCRT proteins in endocytic membrane trafficking. Exp. Cell Res. 2008, 314, 801-813.
57. Bjarnason, I.; Peters, T.J. In vitro determination of small intestinal permeability: Demonstration of a persistent defect in patients with coeliac disease. Gut 1984, 25, 145-150.
58. Bjarnason, I.; Marsh, M.N.; Price, A.; Levi, A.J.; Peters, T.J. Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis. Gut 1985, 26, 1214-1219.
59. Sander, G.R.; Cummins, A.G.; Henshall, T.; Powell, B.C. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett. 2005, 579, 4851-4855.
60. Ciccocioppo, R.; Finamore, A.; Ara, C.; di Sabatino, A.; Mengheri, E.; Corazza, G.R. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am. J. Clin. Pathol. 2006, 125, 502-511.
61. Schulzke, J.D.; Bentzel, C.J.; Schulzke, I.; Riecken, E.O.; Fromm, M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr. Res. 1998, 43, 435-441.
62. Rauhavirta, T.; Lindfors, K.; Koskinen, O.; Laurila, K.; Kurppa, K.; Saavalainen, P.; Mäki, M.; Collin, P.; Kaukinen, K. Impaired epithelial integrity in the duodenal mucosa in early stages of celiac disease. Transl. Res. 2014, 164, 223-231.
63. Wapenaar, M.C.; Monsuur, A.J.; van Bodegraven, A.A.; Weersma, R.K.; Bevova, M.R.; Linskens, R.K.; Howdle, P.; Holmes, G.; Mulder, C.J.; Dijkstra, G., et al. Associations with tight junction genes PARD3 and MAGI2 in dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008, 57, 463-467.
64. Jauregi-Miguel, A.; Fernandez-Jimenez, N.; Irastorza, I.; Plaza-Izurieta, L.; Vitoria, J.C.; Bilbao, J.R. Alteration of tight junction gene expression in celiac disease. J. Pediatr. Gastroenterol. Nutr. 2014, 58, 762-767.
65. Trynka, G.; Hunt, K.A.; Bockett, N.A.; Romanos, J.; Mistry, V.; Szperl, A.; Bakker, S.F.; Bardella, M.T.; Bhaw-Rosun, L.; Castillejo, G., et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 2011, 43, 1193-1201.
66. Almeida, R.; Ricaño-Ponce, I.; Kumar, V.; Deelen, P.; Szperl, A. Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variant. Hum. Mol. Gent. 2014, doi:10.1093/hmg/ddt619. Available online: http://hmg.oxfordjournals.org/content/early/2013/12/19/hmg.ddt619.short (accessed on 11 December 2013).
67. Grunewald, T.G.; Pasedag, S.M.; Butt, E. Cell adhesion and transcriptional activity-defining the role of the novel protooncogene LPP. Transl. Oncol. 2009, 2, 107-116.
68. Nanayakkara, M.; Kosova, R.; Lania, G.; Sarno, M.; Gaito, A.; Galatola, M.; Greco, L.; Cuomo, M.; Troncone, R.; Auricchio, S., et al. A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43. PLoS One 2013, 8, e79763.
69. Fernandez-Jimenez, N.; Castellanos-Rubio, A.; Plaza-Izurieta, L.; Irastorza, I.; Elcoroaristizabal, X.; Jauregi-Miguel, A.; Lopez-Euba, T.; Tutau, C.; de Pancorbo, M.M.; Vitoria, J.C., et al. Coregulation and modulation of NF-κB-related genes in celiac disease: Uncovered aspects of gut mucosal inflammation. Hum. Mol. Genet. 2014, 23, 1298-1310.
70. Trynka, G.; Zhernakova, A.; Romanos, J.; Franke, L.; Hunt, K.A.; Turner, G.; Bruinenberg, M.; Heap, G.A.; Platteel, M.; Ryan, A.W., et al. Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling. Gut 2009, 58, 1078-1083.
71. Hayden, M.S.; Ghosh, S. NF-κB in immunobiology. Cel. Res. 2011, 21, 223-244.
72. Stone, K.P.; Kastin, A.J.; Pan, W. NF-κB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol. Biochem. 2011, 28, 115-124.
73. Nanayakkara, M.; Lania, G.; Maglio, M.; Kosova, R.; Sarno, M.; Gaito, A.; Discepolo, V.; Troncone, R.; Auricchio, S.; Auricchio, R., et al. Enterocyte proliferation and signaling are constitutively altered in celiac disease. PLoS One 2013, 8, e76006.
74. Iltanen, S.; Rantala, I.; Laippala, P.; Holm, K.; Partanen, J.; Maki, M. Expression of HSP-65 in jejunal epithelial cells in patients clinically suspected of coeliac disease. Autoimmunity 1999, 31, 125-132.
75. Sziksz, E.; Veres, G.; Vannay, A.; Prókai, A.; Gál, K.; Onody, A.; Korponay-Szabó, I.R.; Reusz, G.; Szabó, A.; Tulassay, T., et al. Increased heat shock protein 72 expression in celiac disease. Pediatr. Gastroenterol. Nutr. 2010, 51, 573-578.
76. Allegretti, Y.L.; Bondar, C.; Guzman, L.; Cueto Rua, E.; Chopita, N.; Fuertes, M.; Zwirner, N.W.; Chirdo, F.G. Broad MICA/B expression in the small bowel mucosa: A link between cellular stress and celiac disease. PLoS One 2013, 8, e73658.
77. Santagata, S.; Ferrara, K.; Discepolo, V.; Auricchio, R.; Auricchio, S.; Troncone, R.; Zanzi, D.; Barone M.V. IL-15 over expression on dendritic cells enhances proliferation of CD8+ T cells in celiac disease. PLoS One 2014, submitted for publication.
78. Doherty, M.; Barry, R.E. Gluten-induced mucosal changes in subjects without overt small-bowel disease. Lancet 1981, 1, 517-520.
79. Ferguson, A.; Blackwell, J.; Barnetson, R. Effects of additional dietary gluten on the small-intestinal mucosa of volunteers and of patients with dermatitis herpetiformis. Scand. J. Gastroenterol. 1987, 22, 543-549.
80. Barone, M.V.; Auricchio, S. Biochemistry and biological properties of gliadin peptides. In Frontiers in Celiac Disease, 2nd ed.; Fasano, A., Troncone, R., Eds.; Karger: Basel, Swiss, 2008; Volume 12, pp. 57-65.
81. Chladkova, B.; Kamanova, J. Gliadin fragments promote migration of dendritic cells. J. Cell Mol. Med. 2011, 15, 938-948.
82. Discepolo, V.; Ten Eikelder, M.L.G.; Santagata, S.; Zanzi, D.; Ferrara, K.; Sepe, L.; Paolella, G.; Nanayakkara, M.; Carrella, C.; Troncone, R., et al. Altered dendritic cell morphology in celiac disease. PLoS One 2014, in press.
83. Lania, G.; Nanayakkara, M.; Maglio, M.; Toncone, R.; Auricchio, S.; Barone, M.V. Constitutive alterations of the endocityc pathway in celiac disease. J. Cell Biol. 2014, submitted for publication.
84. Bernardo, D.; Garrote, J.A.; Fernández-Salazar, L.; Riestra, S.; Arranz, E. Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides. Gut 2007, 56, 889-890.
85. De Palma, G.; Kamanova, J.; Cinova, J.; Olivares, M.; Drasarova, H.; Tuckova, L.; Sanz, Y. Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: Relevance for celiac disease. J. Leukoc. Biol. 2012, 92, 1043-1054.
86. Junker, Y.; Zeissig, S.; Kim, S.J. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of Toll-like receptor 4. J. Exp. Med. 2012, 209, 2395-2408.
87. Savilahti, E.; Ormälä, T.; Saukkonen, T.; Sandini-Pohjavuori, U.; Kantele, J.M.; Arato, A.; Ilonen, J.; Akerblom, H.K. Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation. Clin. Exp. Immunol. 1999, 116, 70-77.
88. Westerholm-Ormio, M.; Vaarala, O.; Pihkala, P.; Ilonen, J.; Savilahti, E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003, 52, 2287-2295.
89. Lefebvre, D.E.; Powell, K.L.; Strom, A. Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu. Rev. Nutr. 2006, 26, 175-202.
90. Troncone, R.; Franzese, A.; Mazzarella, G. Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus. Am. J. Gastroenterol. 2003, 98, 590-595.
91. Auricchio, R.; Paparo, F.; Maglio, M.; Franzese, A.; Lombardi, F.; Valerio, G.; Nardone, G.; Percopo, S.; Greco, L.; Troncone, R. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 2004, 53, 1680-1683.